Broncus Holding's (HKG:2216) medical device BroncTarget has entered a special review in China, according to a Hong Kong bourse filing Monday.
The device entered China's Innovative Medical Device Special Review Procedure to treat a lung condition known as chronic obstructive pulmonary disease.
The designation offers multiple benefits, including faster reviews.